JB300

Kundenbewertung

Based on 1 Customer Validation

JB300 is a highly selective Aurora A degrader based on PROTAC technology (DC50=30 nM). JB300 can be used for tumor research. JB300 consists of PROTAC target protein ligand MK-5108 (HY-13252) (pink part), E3 ligase ligand Thalidomide-O-COOH (HY-103597) (blue part) and PROTAC Linker Boc-NH-PEG2-C2-NH2 (HY-W008474) (black part), of which the conjugate of E3 ubiquitin ligase ligand + Linker is Thalidomide-O-COOH-NH2-C2-PEG2-NH-Boc (HY-172145).
(Pink: Aurora A ligand (HY-13252); Blue: Cereblon ligand (HY-103597); Black: linker (HY-W008474)).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98%
  • CAS. Nr.: 3038446-90-8
  • Formel: C43H45ClFN7O10S
  • Molecular Weight:906.37
  • Speicherung:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle PROTACs Isoform-spezifische Produkte anzeigen

More

Alle Aurora Kinase Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00